Exocytosis

How Exocytosis Works

Exocytosis is the reverse of endocytosis - releasing material from inside the cell:

1. Vesicle transport - Secretory vesicles move toward plasma membrane
2. Tethering - Vesicles attach near target membrane
3. Docking - Vesicles make close contact with membrane
4. Priming - Molecular machinery prepares for fusion
5. Fusion trigger - Usually calcium influx
6. Membrane fusion - Vesicle and plasma membrane merge
7. Content release - Cargo released into extracellular space

Types of Exocytosis

Regulated Exocytosis

Occurs in response to specific signals:

• Hormone secretion
• Neurotransmitter release
• Requires trigger (usually calcium)
• Rapid, precisely controlled

Constitutive Exocytosis

Continuous, signal-independent:

• Membrane protein delivery
• Extracellular matrix secretion
• Maintains cell surface

Exocytosis in Hormone Secretion

Insulin Secretion from Beta Cells

Glucose enters beta cell
        ↓
Metabolism produces ATP
        ↓
KATP channels close
        ↓
Membrane depolarizes
        ↓
Voltage-gated Ca2+ channels open
        ↓
Ca2+ influx triggers exocytosis
        ↓
Insulin granules fuse with membrane
        ↓
Insulin released into bloodstream

GLP-1 receptor agonists enhance this process by:

• Increasing cAMP (amplifies calcium signal)
• Promoting granule priming
• Increasing readily releasable pool of vesicles

Growth Hormone Secretion

GHRH or Ghrelin binds receptor
        ↓
Signaling cascades activate
        ↓
Ca2+ increases in somatotrophs
        ↓
GH granule exocytosis
        ↓
GH released in pulses

Peptides like ipamorelin and GHRP-6 trigger this release by activating ghrelin receptors.

Molecular Machinery of Exocytosis

SNARE Proteins

Core fusion machinery:

Protein	Location	Function
Syntaxin	Plasma membrane	Target SNARE
SNAP-25	Plasma membrane	Target SNARE
VAMP/Synaptobrevin	Vesicle	Vesicle SNARE

SNARE proteins on vesicle and target membrane zipper together to drive fusion.

Regulatory Proteins

• Synaptotagmin: Calcium sensor that triggers fusion
• Munc18: Regulates SNARE assembly
• Complexin: Controls fusion competence
• Rab proteins: Guide vesicle trafficking

Calcium as the Trigger

Calcium is the universal trigger for regulated exocytosis:

Source	Mechanism	Speed
Voltage-gated channels	Membrane depolarization	Milliseconds
Store release	IP3 from receptor signaling	Seconds
Receptor-operated channels	Direct receptor activation	Variable

Low resting calcium (~100 nM) rises to over 10 uM locally to trigger fusion.

Vesicle Pools

Secretory cells maintain different pools of vesicles:

Reserve Pool (90% of vesicles)
        ↓
    Mobilization
        ↓
Docked Pool (at membrane)
        ↓
    Priming
        ↓
Readily Releasable Pool (immediate release)
        ↓
    Ca2+ trigger
        ↓
Exocytosis

GLP-1 agonists increase the readily releasable pool, enhancing glucose-stimulated insulin secretion.

Clinical Relevance

Type 2 Diabetes

Defective exocytosis contributes to insulin secretion failure:

• Reduced readily releasable pool
• Impaired calcium signaling
• SNARE protein changes
• GLP-1 agonists help restore secretory function

Growth Hormone Deficiency

May involve impaired GH exocytosis:

• Reduced pituitary response to GHRH
• Growth hormone secretagogues bypass some defects
• Pulsatile release pattern important for effects

Frequently Asked Questions

Why is calcium required for hormone secretion?

Calcium serves as the final trigger that tells secretory vesicles to fuse with the plasma membrane. Synaptotagmin proteins on vesicles act as calcium sensors - when calcium binds, they undergo conformational changes that drive the final fusion step. This calcium requirement ensures hormones are released only when appropriate signals are present.

How do GLP-1 agonists enhance insulin secretion?

GLP-1 agonists increase cAMP in beta cells, which amplifies calcium signals and prepares more vesicles for release. Importantly, they enhance glucose-stimulated secretion rather than causing release regardless of glucose. This glucose-dependency makes them safer than older drugs that directly trigger exocytosis.

Can exocytosis be too active?

Yes. Excessive exocytosis can deplete vesicle pools, leading to secretory fatigue. This is one reason why continuous high stimulation of beta cells can eventually impair insulin secretion. Pulsatile signaling allows vesicle pools to replenish between secretory episodes.